Journal of cardiac failure Journal

•  
• Overview
•  
• Identity
•  
• View All
•  

Overview

publication venue for

• Clinician Insights into Effective Components, Delivery Characteristics and Implementation Strategies of Ambulatory Palliative Care for People with Heart Failure: A Qualitative Analysis. 2024
• Long-term Changes in Body Composition and Exercise Capacity Following Calorie Restriction and Exercise Training in Older Patients with Obesity and Heart Failure With Preserved Ejection Fraction. 2024
• Sex-Based Differences in the Epidemiology, Clinical Characteristics, and Outcomes Associated with Worsening Heart Failure Events in a Learning Health System..  30:981-990. 2024
• Palliative Care Education in Cardiovascular Disease Fellowships: A National Survey of Program Directors. 2024
• Cognitive Impairment Is Our Job Too..  30:423-424. 2024
• Cognitive Impairment in Heart Failure: A Heart Failure Society of America Scientific Statement..  30:488-504. 2024
• Malnutrition and Sarcopenia as Reasons for Caution with GLP-1 Receptor Agonist Use in HFpEF..  30:610-612. 2024
• Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: Rationale, Design and Lead-in Phase Results of the REBALANCE-HF Trial..  30:877-889. 2024
• Factors Associated With Mortality and Hospice Use Among Medicare Beneficiaries With Heart Failure Who Received Home Health Services..  30:788-799. 2023
• Doing Harm by Doing No Harm? Resisting the Urge to Retire GDMT in Older Adults With Heart Failure..  29:445-447. 2023
• Assessment of Biomarkers of Myocardial injury, Inflammation, and Renal Function in Heart Failure With Reduced Ejection Fraction: The VICTORIA Biomarker Substudy..  29:448-458. 2023
• Subjective Financial Hardship due to Medical Bills Among Patients With Heart Failure in the United States: The 2014-2018 Medical Expenditure Panel Survey..  28:1424-1433. 2022
• Longitudinal Changes in Cardiac Troponin and Risk of Heart Failure Among Black Adults..  29:6-15. 2022
• Association of Perceived Stress With Incident Heart Failure..  28:1401-1410. 2022
• Digging Deeper: Understanding Trajectories and Experiences of Shared Decision-Making for Primary Prevention ICD Implantation..  28:1437-1444. 2022
• All-Cause Mortality as an End Point for Heart Failure With Preserved Ejection Fraction: Underperformance or Overambitious?.  28:863-865. 2022
• Moving the Field Forward: Untangling the Impact of Frailty on Patients With Advanced Heart Failure and on Prognosticating Outcomes..  28:775-777. 2021
• Prescriptions for Potentially Inappropriate Medications from the Beers Criteria Among Older Adults Hospitalized for Heart Failure..  28:906-915. 2021
• Left Atrial Stiffness Index Independently Predicts Exercise Intolerance and Quality of Life in Older, Obese Patients With Heart Failure With Preserved Ejection Fraction..  28:567-575. 2021
• Clinical Implications of the Amyloidogenic V122I Transthyretin Variant in the General Population..  28:403-414. 2021
• Older Patients With Acute Decompensated Heart Failure Who Live Alone: An Analysis From the REHAB-HF Trial..  28:161-163. 2021
• Relationships Between Objectively Measured Physical Activity, Exercise Capacity, and Quality of Life in Older Patients With Obese Heart Failure and Preserved Ejection Fraction..  27:635-641. 2021
• The Dietary Approaches to Stop Hypertension (DASH) Diet Pattern and Incident Heart Failure..  27:512-521. 2021
• Delirium Among Hospitalized Older Adults With Acute Heart Failure Exacerbation..  27:453-459. 2021
• Social Determinants of Health and Rates of Implantation for Patients Considering Destination Therapy Left Ventricular Assist Device..  27:497-500. 2020
• Inclusion of Performance Parameters and Patient Context in the Clinical Practice Guidelines for Heart Failure..  27:190-197. 2020
• Cognition, Physical Function, and Quality of Life in Older Patients With Acute Decompensated Heart Failure..  27:286-294. 2020
• Performance of Electronic Health Record Diagnosis Codes for Ambulatory Heart Failure Encounters..  26:1060-1066. 2020
• Cardiac Rehabilitation: You Can't Have "Too Much of a Good Thing"..  26:652-653. 2020
• Electrocardiographic Findings in Coronavirus Disease-19: Insights on Mortality and Underlying Myocardial Processes..  26:626-632. 2020
• Virtual Visits for Care of Patients with Heart Failure in the Era of COVID-19: A Statement from the Heart Failure Society of America..  26:448-456. 2020
• Association of Hospital Volume with 30-Day Readmission Following Left Ventricular Assist Device Implantation..  26:349-351. 2020
• Age and Heart Failure Trials - Lessons from DAPA-HF..  26:191-192. 2020
• Beta-Blockers for Primary Therapy of Heart Failure With Preserved Ejection Fraction: An Idea Whose Time Has Gone?.  26:283-284. 2020
• Endoscopic Algorithm for Management of Gastrointestinal Bleeding in Patients With Continuous Flow LVADs: A Prospective Validation Study..  26:324-332. 2019
• Do We Need Shared Decision Making When Prescribing Guideline-Directed Medical Therapy?.  25:701-702. 2019
• The Prevalence of Cognitive Impairment Among Adults With Incident Heart Failure: The "Reasons for Geographic and Racial Differences in Stroke" (REGARDS) Study..  25:130-136. 2018
• Lower-Extremity Function as a Marker of Frailty and Outcomes of Heart Failure With Preserved Ejection Fraction in Older Adults..  25:10-11. 2018
• Use of Heart Failure-Exacerbating Medications Among Adults With Heart Failure..  25:72-73. 2018
• Resting Heart Rate and Chronotropic Response to Exercise: Prognostic Implications in Heart Failure Across the Left Ventricular Ejection Fraction Spectrum..  24:753-762. 2018
• Estimation of Incident Heart Failure Risk among US Hispanics/Latinos Using a Validated Echocardiographic Risk-Stratification Index: the Echocardiographic Study of Latinos..  24:622-624. 2018
• Processes and Outcomes of Congestive Heart Failure Care by Different Types of Primary Care Models..  24:9-18. 2017
• Evidence of Cognitive Bias in Decision Making Around Implantable-Cardioverter Defibrillators: A Qualitative Framework Analysis..  23:794-799. 2017
• Growing Relevance of Cardiac Rehabilitation for an Older Population With Heart Failure..  22:1015-1022. 2016
• Skilled Nursing Facility Care for Patients With Heart Failure: Can We Make It "Heart Failure Ready?"..  22:1004-1014. 2016
• Analysis of Skeletal Muscle Torque Capacity and Circulating Ceramides in Patients with Advanced Heart Failure..  22:347-55. 2016
• Anchoring in Destination-Therapy Left Ventricular Assist Device Decision Making: A Mechanical Turk Survey..  22:908-912. 2016
• Deactivation of Left Ventricular Assist Devices: Differing Perspectives of Cardiology and Hospice/Palliative Medicine Clinicians..  23:708-712. 2016
• Patient Perspectives on Communication of Individualized Survival Estimates in Heart Failure..  23:272-277. 2016
• Response to Exercise Training and Outcomes in Patients With Heart Failure and Diabetes Mellitus: Insights From the HF-ACTION Trial..  22:485-91. 2015
• Vascular Dysfunction in Heart Failure with Preserved Ejection Fraction..  22:12-6. 2015
• Exercise training and pacing status in patients with heart failure: results from HF-ACTION..  21:60-7. 2014
• Use of intravenous diuretics on day of discharge in adults hospitalized for heart failure..  20:706-7. 2014
• Getting a grip on frailty: handgrip strength in patient selection for left ventricular assist device..  20:316-8. 2014
• Relationship between galectin-3 levels and mineralocorticoid receptor antagonist use in heart failure: analysis from HF-ACTION..  20:38-44. 2013
• Risk factors for onset of disability among older persons newly diagnosed with heart failure: the Cardiovascular Health Study..  17:764-70. 2011
• Regional variations in physicians' attitudes and recommendations surrounding implantable cardioverter-defibrillators..  17:318-24. 2011
• Symptoms characteristic of heart failure among CKD patients without diagnosed heart failure..  17:17-23. 2011
• Patient perspectives on decision making in heart failure..  16:823-6. 2010
• Impaired kidney function and atrial fibrillation in elderly subjects..  16:55-60. 2009
• Cystatin C concentration as a predictor of systolic and diastolic heart failure..  14:19-26. 2008
• Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: data from the Heart and Soul Study..  12:601-7. 2006

Identity

International Standard Serial Number (ISSN)

• 1532-8414